Donepezil (also misspelled donezepil), marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer’s disease where it is used to increase cortical acetylcholine. Its binding to the acetylcholinesterase can be seen at Proteopedia 1eve. It has an oral bioavailability of 100% and easily crosses the blood-brain barrier. Because it has a half life of about 70 hours, it can be taken once a day. Initial dose is 5mg per day, which can be increased to 10mg per day after an adjustment period of at least 4 weeks.
Integrity is important to us. We follow strict Health Product and EUR GDP guidelines. Quality for us is much more than warehouse setup and chain of supply.Read More
We care about our customers. Gaia Trade offers fast and efficient global customer support.Commitment to customer service and a quality product is our core value.Read More
Exporting pharmaceutical products worldwide. With our network we are able to source almost any product required by our clients.Read More